Atopy was a term introduced by Coca & Cooke (1923) to describe the syndrome of common allergic diseases-hay fever, asthma, atopic eczema and urticaria-which had a genetic basis. The conundrum exists to this day as to why this complex immune system, involving B cells producing predominantly the IgE class of antibodies and a regulatory T cell system, basophils, mast cells and eosinophils, should be maintained when it apparently turns harmless environmental antigens into allergens detrimental to the health of the host. Teleologically, the most plausible explanation is that this system evolved as a protection against helminthic infestation, although the role that antibodies of IgE class play in helminthic immunity has not clearly been established (Ogilvie & Jones, 1973) . In developed countries where public health measures have all but eradicated the major helminthic parasites it is possible that this system has become redundant and its expression in hyper-reactive individuals is atopic disease.
Another role has been suggested for IgE in protective immunity against cancer. Early studies purported to show that the incidence of atopy was decreased in cancer patients (Fisherman, 1960; Mackay, 1966) but subsequent large controlled studies were unable to verify the earlier claims (McKee et al., 1967; Shapiro et al., 1971 ) and the consensus of opinion now is that the presence of atopy does not protect against oncogenesis (for review, see Rosenbaum & Dwyer, 1977) . However none of these studies examined how atopic cancer patients fared compared to their non-atopic counterparts. The present study examines the effect of pre-existing atopy on the survival of patients with Hodgkin's disease (HD) as well as other parameters of disease expression. From the standpoint of allergic disease, HD is a particularly apt example of malignancy because like helminthic parasites it is associated with raised levels of serum IgE (Waldman et al., 1974; Amlot & Green, 1978) and eosinophilia. The reported frequency of atopy in HD is normal (Amlot & Green, 1978; Dworin et al., 1955; McCormick et al., 1971) Staging of the patients accorded with the Ann Arbor system (Carbone et al., 1971) . Clinical staging routinely included lymphography and bone marrow trephine biopsy. Selective staging laparotomy and splenectomy were carried out in 74 cases. Prior unequivocal "B" symptoms (59 patients), contraindication to operation (8 patients) and clinical stage IA disease with lymphocyte predominance or nodular sclerosis (7 patients) were reasons for not performing staging laparotomies in the remainder.
Histology was classified according to Lukes & Butler (1966) and grouped as lymphocyte predominance (LP), nodular sclerosis (NS), mixed cellularity (MC) or lymphocyte depletion (LD).
Atopic symptoms
Past or present personal histories of hay fever, perennial rhinitis, asthma, atopic eczema or urticaria and similar family histories were elicited from each patient. Questionnaires were sent to each member of the patient's direct family requesting the same information and were answered by all except 11 families. Doubtful symptoms, drug allergies, contact dermatitis and atopy evidently arising from the unaffected spouse's side of the family were disregarded. Family history extended to grandparents, parents, siblings, children, uncles, aunts and first cousins.
Patients were stratified on atopic status according to their atopic history and pre-treatment serum IgE level. Group 1 were those with a personal history of atopy; Group 2 had a family history but no personal history of atopy; Groups 3 and 4 had neither personal nor family history of atopy but had high and normal levels of serum IgE respectively.
Measurement of IgE
This was performed on a pre-treatment serum sample from all patients using a double antibody radio-immuno assay (Amlot & Green, 1978) . Normal IgE levels were determined from 275 healthy, non-atopic subjects whose geometric mean IgE was 15IUml-1 (loglo1.8+0.51). The upper limit for normal IgE levels was set at 159IUml-1 (antilog log, 01.18+2 x 0.51).
Prick tests were performed on the majority of patients using a battery of common inhalant allergens described recently elsewhere (Amlot & Slaney, 1981 (Nicholson et al., 1970 (Peto et al., 1977) using the London School of Hygiene and Tropical Medicine's version of the Surv-C programme (Peto et al., 1977) and run at the University of London Computer Centre. Allowance was made for prognostic factors which were shown to affect survival. Statistical analysis elsewhere was by x2 for contingency tables.
Results
The characteristics of the groups 1-4 in respect of atopy are shown in Table I . In Group 1 the complete atopic diathesis was seen with atopic symptoms, positive prick tests and elevated IgE levels, while Group 2 shared with it an increased frequency of positive prick tests and moderately raised IgE levels having antibody activity for common inhalant allergens (shown previously by RAST) (Amlot & Slaney, 1981) . Group 3 had the highest IgE levels but in this group the IgE rarely had demonstrable allergen specific antibody, (Amlot & Slaney, 1981) . Group 4 showed no evidence of atopy apart from a low incidence of positive prick tests. This stratification graded patients with unequivocal atopy through to those with least evidence of atopy.
Prognostic factors affecting survival in HD These are shown in Table II . The known prognostic factors can be divided into 2 types. First, those like age and sex which precede and are separate from the disease process but which somehow modify the disease. Second, those factors like stage, symptoms and histology which are expressions of the severity of the disease. The reasons for the degree of severity in an individual patient are unknown. The widely described effect of stage, symptoms and histology on prognosis was again confirmed by this study. Less often reported is the influence of age on survival (Axtell et al., 1972) which has disclosed a markedly decreased survival in older patients. The age analysis shown in Table II divided patients into those above and below 40 years of age because this corresponded with the trough between the 2 peaks of the bimodal age distribution in HD. However, a number of age strata were analysed and all showed an adverse prognosis in age groups >40 years, and the prognosis was worse the older the age grouping. The relative death rates for the 2 age groups were little changed and still significant after stratification for stage (P=0.0001), symptoms (P=0.0001) and histology (P=0.0006).
Females had a slightly improved survival compared with males but this was not significant.
The novel discovery in this study was the significant effect of atopic stratification related to survival in HD (Figure 1 ). When survival of these 0 0-
. 29, 24, 20, 15, 13, 8 & 7. Group 2: 26, 23, 19, 11, 8, 4 & 2. Group 3: 31, 21, 17, 12, 11, 5 & 1. Group 4: 62, 40, 25, 21, 16, 9 & 4. groups was analysed (Table II) (Amlot & Green, 1978 The atopic groups were compared after stratification with respect to age (<40 y, .40 y), symptoms and histology (Table VI) . There was still a significant trend (P = 0.004) in the adjusted relative death rates from 0.37 in Group 1 to 1.36 in Group 4. Clearly the patients of Group 4 differed from those of the other 3 and those in groups 1 and 2 were very similar both in their relative death rates (Tables V and VI ) and in having a history of atopic symptoms either in themselves or in their families. Group 3 patients had very high IgE levels but no atopy and their relative death rate was closer to those of Groups 1 and 2 and it could be shown that the relative death rates for Groups 1, 2 and 3 did not differ significantly (P=0.4). On the other hand Group 4 had a significantly worse prognosis than groups 1, 2 and 3 combined after stratification for age symptoms and histology (P= 0.03).
Patients .60 y had the worst survival and group 4 had a mu'ch higher percentage of these older patients than the other groups. The stratification for age in the previous analysis was for those <40 y or .40 y. In view of the number of subgroups already in the analysis and that the atopic groups 1, 2 and 3 had 3 or less aged 60 or over, it was undesirable to repeat the previous analysis with the .40y group split into 40-59y and 60 y. However the analysis was repeated excluding those >60 y. The relative death rates were very similar to those of the preceeding analysis and are shown in Table VI .
Cause of death In the majority of deaths the primary cause was HD and there was no clear difference in cause of death between the atopic strata. Complicated deaths from other causes were: in Group 1, one patient with paraplegia had renal infection and recurrent septicaemia and another had a hypereosinophilic state (50,000 ,ul-1) followed by acute tubular necrosis subsequent to laparotomy while both were in relapse. In Group 2 one patient died of acute myeloid leukaemia while in CR. In Group 3 three patients died in CR, one from myocardial infarction, and the other two from carcinoma of the lung. In Group 4 one patient died from peritonitis while in CR, one from complications of paraplegia while in relapse, one from multiple system failure with minimal hepatic HD and one patient who died at home while in relapse. Excluding the patients above re-analysis of survival still showed a highly significant trend (P<0.0001) for atopic strata.
Discussion
Atopic status was stratified in this study because it is known to be a multifactorial disease often having a late onset. Thus apart from those patients who had clearly suffered from atopic symptoms prior to developing HD (Group 1) there was a group of patients with a genetic predisposition to atopy many of whom had evidence of atopic hypersensitivity without having developed atopic symptoms (Group 2). The peak age for subjects developing hay fever lies, like HD, in the third decade and its development is more prevalent in those with a family history of atopy. Even in those Groups 3 and 4 where atopy was not evident there were occasional individuals with positive prick tests and who therefore risked development of atopic symptoms at a later date. The relationship between prolonged survival and positive prick tests will be dealt with in a subsequent paper. Comparison of survival, prompted initially by the observation that atopic patients (Group 1) rarely had "B" symptoms, led to the discovery that this atopic c stratification was associated with survival whereby atopy had a favourable effect even after stratification for age, symptoms and histology. (Lukes & Butler, 1966; Coppleson et al., 1973) . Although there is clear evidence that the higher the ratio of lymphocytes and "benign" histiocytes to Hodgkin's cells the better the prognosis, no direct evidence of lymphocyte cytotoxicity towards Hodgkin's or RS cells has been forthcoming. This work has been hampered by the difficulty in isolating and establishing tissue culture lines of Hodgkin's cells against which lymphocytes could be tested.
Interest in factors preceding the development of HD yet affecting its final outcome lies in the possibility of identifying host resistance mechanisms for HD. Age of onset is clearly an important factor. Although the effect of age is independent of the other prognostic variables, among 19 in the older age group (.60y) there was a 95% frequency of MC or LD histology and a 63% frequency of Stage IIIB or IVB. These findings were similar to the same age group reported by Lokich et al., (1974) in which 83% of 47 patients had MC or LD histology and 81% had stage III or IV disease. Median survival of 5 months was very poor and may partly have been explained by the palliative treatment given in some cases. We attempted to give full treatment in this group and still only achieved a median survival of 10 months for the 12 who had died during the study period. Older patients tolerated full dosage of treatment poorly and prolonged bouts of myelosuppression with its associated complications probably played a significant part in the poor results. Evidently age per se is not a manipulable resistance factor and the lack of resistance to HD in the .60 y old patients does not define the causative factors.
The recognition of atopy as having a favourable effect upon survival in HD raises interest in the possible mechanism by which it acts. Atopy is a complex disorder involving immunological mechanisms of immediate hypersensitivity as well as non-immunological ones such as increased sensitivity to a adrenergic stimuli and decreased f adrenergic receptors. However, it is the vigorous production of IgE antibodies in response to low doses of antigen that is the most clearly defined feature. Consequently the protective mechanism most readily suggested is the production of antitumour IgE antibody and limitation of disease spread as a result of tissue sensitisation and the action of accessory effector cells. It is known that rodent melanoma and fibrosarcoma induce specific reaginic responses (Bartholomaeus & Kaest, 1972; Broom & Alexander, 1975) . Furthermore there have been suggestions of both basophil (Dvorak et al., 1973) and mast cell (Likhite, 1974) (Grace & Kondo, 1958) in contrast to those frequently reported in helminthic disease.
A less obvious means by which atopy may influence tumour growth is based on the cellular mechanisms underlying control IgE antibody production. It is not surprising that the potentially damaging IgE antibody is under strong T lymphocyte suppressor control which is presumably abnormal in atopic subjects. Helminthic parasites can stimulate IgE synthesis with loss of suppressor control during infestation. It was found that tumour growth is inhibited in rodents infested with helminths (Keller et al., 1971) . In these experiments no reaginic antitumour antibody was demonstrated but surprisingly the tumour inhibition was abolished when rodents were treated with antilymphocyte antiserum. At the time it was difficult to interpret these results but development of specific antisera for rodent supressor cells has demonstrated that tumour growth may be inhibited when suppressor cells are eradicated (Perry et al., 1978; Tilkin et al., 1981) . These studies suggest that in normal individuals the powerful suppressor control of IgE synthesis may be linked to suppressor control of cellular responses towards weak antigenic systems such as tumour antigens. Abrogation of suppressor control may paradoxically benefit the tumour bearing host. It may also be relevant that in both these experimental systems tumour growth was inhibited but not abolished which is similar to the effect of atopy in HD. HD is a variable disease that runs a variable course. Assuming that it is a single disease entity and that its different manifestations and progression are reflections of a "host-tumour interaction" then factors that influence it are of interest for their positive and negative effects on prognosis. This study shows that atopy is a factor that precedes the development of HD and correlates favourably with its outcome.
